Vacancy for Pharmacist in Central Organisation, ECHS Haldwani
16 June 2026

Vacancy for Pharmacist in Central Organisation, ECHS Haldwani

ECHS invites applications to engage following Medical, Para Medical. & Non Medical Staff on contractual basis in ECHS Polyclinic Haldwani for a period of one year renewable for additional period of one year, till attaining the maximum age subject to performance of candidates.
16 June 2026
Intas Pharma Hiring Research Associate
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world.
16 June 2026
Walk in drive for Quality Control and Production at Mankind Pharma
Person should have the worked on Peptide Manufacturing & Peptide Synthesis and Exposure to Peptide Synthesis, purification, filtration and drying processes and Peptides synthesis, Peptide purification, Lyophilization.
16 June 2026
Multiple Openings for Pharma and Science candidates at RPG Life Sciences
RPG LIFE SCIENCES LIMITED, ARE INVITING CANDIDATURE FROM PROFESSIONALS FOR BELOW MENTIONED POSITIONS
16 June 2026
Join the Business Development Team of Vivo Bio Tech Ltd - Pharmacy or Life Sciences apply
Masters Degree in Pharmacy or Life Sciences; MBA preferred. Strong understanding of Preclinical Testing Services and business development processes.
16 June 2026
Walk in drive for API & CDMO Plants at Cohance Lifesciences
Walk in interviews in Hyderabad for our API and CDMO Plants at Telangana and Andhra Pradesh
16 June 2026
Lilly Highlights Retatrutide’s Potential as Next-Generation Treatment for Obesity and Related Conditions

Eli Lilly has provided new insights into retatrutide, its investigational medicine that is attracting significant attention for its potential to treat obesity, type 2 diabetes, and several obesity-related health conditions. While the therapy remains under clinical development and is not yet approved for public use, ongoing research suggests it could become one of the most impactful treatments in the rapidly growing obesity care market.

16 June 2026
New Blood Test May Help Predict Recurrence and Survival in Head and Neck Cancer Patients

Researchers at Mass General Brigham have developed a promising blood test that could help physicians identify head and neck cancer patients at higher risk of disease recurrence and poorer survival outcomes, potentially enabling more personalized treatment strategies and follow-up care.

16 June 2026
FDA Approves Merck’s KEYTRUDA Combination Therapy for Certain Kidney Cancer Patients

Merck has announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), as well as the newly approved subcutaneous formulation KEYTRUDA QLEx™, in combination with WELIREG® (belzutifan) for the adjuvant treatment of certain patients with renal cell carcinoma (RCC), the most common form of kidney cancer.

16 June 2026
AI Expands Pharmaceutical Marketing Beyond Physicians to Full Care Teams

As healthcare delivery becomes increasingly team-oriented, pharmaceutical marketers are being encouraged to look beyond physicians and engage a broader network of healthcare professionals involved in patient care. According to a recent announcement from IQVIA Digital, artificial intelligence is helping marketers identify and connect with nurse practitioners (NPs), physician associates (PAs), and other key members of collaborative care teams who play a growing role in treatment decisions.